Great Point Partners, LLC 13D and 13G filings for Constellation Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-02-16 4:13 pm Sale | 2020-12-31 | 13G | Constellation Pharmaceuticals, Inc. CNST | Great Point Partners, LLC | 1,024,800 2.150% | -1,276,657![]() (-55.47%) | Filing |
2020-06-05 5:00 pm Purchase | 2020-05-26 | 13G | Constellation Pharmaceuticals, Inc. CNST | Great Point Partners, LLC | 2,301,457 5.500% | 2,301,457![]() (New Position) | Filing |